Planet Labs PBC filings document an Earth-observation company that provides satellite imagery, geospatial data, and related software solutions. The company’s 8-K reports include operating results, Regulation FD disclosures, material agreements, and other events tied to its commercial and government satellite-data business.
Recent filings also describe capital-structure matters involving Class A common stock, Class B common stock, earnout share issuances, and public warrants originally issued with IPO units. The record includes warrant redemption disclosures and a Form 25 covering removal of the redeemable warrants from NYSE listing and registration.
Planet Labs PBC (PL) Form 144 notice: The filer intends to sell 42,916 warrants through Morgan Stanley Smith Barney (NYSE) with an aggregate market value of $139,369.71, with an approximate sale date of 09/29/2025. The warrants were acquired as Founder Stock on 03/05/2021 and payment at acquisition was cash. The filing discloses prior warrant sales by Isalea Investments LP totaling 772,291 warrants during Aug–Sep 2025 for gross proceeds of $1,536,598.88. There are 12,833,315 warrants outstanding, so the recent three‑month sales represent about 6.0% of outstanding warrants. The notice includes the standard representation that the seller is unaware of undisclosed material adverse information.
Planet Labs PBC furnished a definitive information statement to notify stockholders that a board election approved by consenting stockholders will become effective 40 days after notice is first sent (notice sent on or about September 22, 2025). The filing describes the company’s corporate governance framework as a Delaware public benefit corporation with a dual-class share structure and identifies board composition, committee memberships, and director independence determinations. It details board risk oversight, lead independent director arrangements, meeting attendance, committee charters, director and executive compensation policies (including reduced outside director cash retainers and equity awards), stock ownership guidelines, severance and change-in-control arrangements, and CEO pay ratio of 33.7:1. The filing also summarizes the Business Combination that created Planet Labs PBC and discusses transition arrangements for a departing executive.
Form 144 notice for Planet Labs PBC (PL) reports a proposed sale of 170,262 warrants through Morgan Stanley Smith Barney on 09/17/2025 with an aggregate market value of $349,633.02. The filer shows these warrants were acquired as Founder Stock on 03/05/2021 and paid in cash. The filing lists recent related sales by ISALEA INVESTMENTS LP totaling 612,029 warrants on 08/19/2025, 09/12/2025 and 09/16/2025 for combined gross proceeds of $1,185,965.86. The filer certifies no knowledge of undisclosed material adverse information and provides the standard Rule 144 representation.
Ashley F. Johnson, President & CFO of Planet Labs PBC (PL), reported stock-based compensation transactions on 09/15/2025. Ms. Johnson received 24,187 shares upon vesting of performance restricted stock units (PSUs) that she elected to receive instead of a cash bonus for the first half of the fiscal year ending January 31, 2026. The issuer withheld 13,267 shares to satisfy withholding tax on those PSUs and 85,404 shares to satisfy withholding tax on vested restricted stock units (RSUs). Following these transactions Ms. Johnson beneficially owned 2,114,714 shares of Class A common stock. The filing discloses 1,436,245 RSUs that vest in equal quarterly installments on March 15, June 15, September 15 and December 15 and represent a contingent right to one share each with no expiration date.
Robert H. Schingler, Co‑Founder, Chief Strategy Officer and director of Planet Labs PBC (PL), reported insider transactions dated 09/15/2025. He received 15,244 shares upon vesting of performance restricted stock units (PSUs) that were issued in lieu of his cash bonus for the first half of fiscal 2026 after electing to convert the earned cash bonus into PSUs. The filing also shows 7,741 and 49,961 shares of Class A common stock withheld by the issuer to satisfy withholding tax liabilities; those withholding transactions are reported at a price of $9.86 per share. Beneficial ownership is reported as 1,428,201, 1,420,460, and 1,370,499 shares following the respective transactions. The filing discloses 933,672 restricted stock units (RSUs) that vest in equal quarterly installments on March 15, June 15, September 15 and December 15 and represent a contingent right to one share each with no expiration date.
Planet Labs PBC insider William Spencer Marshall reported multiple equity changes on 09/15/2025. He acquired 36,586 shares of Class A common stock upon the vesting of performance restricted stock units that replaced his cash bonus for the first half of the fiscal year ending January 31, 2026. The filing shows two withholding transactions: 18,579 shares withheld for taxes related to PSU vesting and 121,897 shares withheld for taxes related to RSU vesting. After these transactions, he beneficially owns 3,356,387 shares of Class A common stock, including 2,309,686 RSUs that vest quarterly and carry a contingent right to one share each with no expiration.
This Form 144 notice reports a proposed sale of 422,335 warrants by Isalea Investments LP, with an aggregate market value of $846,021.47. The warrants represent part of 12,833,315 outstanding units and the approximate sale date is 09/16/2025 on the NYSE. The filer acquired the warrants as founder stock from the issuer on 03/05/2021 and records the original payment as cash. The filing also discloses two recent warrant sales by the same account in the prior three months: 169,694 warrants sold on 09/12/2025 for $339,727.39, and 10,000 warrants sold on 08/19/2025 for $10,217.00. The signer affirms there is no undisclosed material adverse information.
Form 144 notice for Planet Labs PBC (PL) reports a proposed sale of 169,694 warrants through Morgan Stanley Smith Barney LLC, with an aggregate market value of $339,727.39. The company’s total warrants outstanding are listed as 12,833,315. The filer states the securities were acquired as founder stock on 03/05/2021 from the issuer and paid in cash on the same date. The proposed approximate sale date is 09/12/2025 on the NYSE. Recent dispositions by ISALEA INVESTMENTS LP over the past three months are disclosed: sales on 08/19/2025 (10,000 warrants, $10,217.00), 06/13/2025 (3,800 warrants, $2,443.40) and 06/12/2025 (8,600 warrants, $5,849.72). The filer signs a standard representation that no undisclosed material adverse information is known.
Planet Labs PBC issued $460 million of 0.50% Convertible Senior Notes due 2030. The Notes bear interest semiannually and mature October 15, 2030, and are convertible into Class A common stock at an initial rate of 83.6715 shares per $1,000 principal (approximately $11.95 per share). Conversion is restricted until specified trigger conditions are met, becoming freely convertible shortly before maturity. The Company may redeem the Notes beginning October 20, 2028 if certain liquidity and stock-price conditions are satisfied.
The Company entered into capped call transactions with several banks with an initial cap price of $18.04 per share to reduce potential dilution and offset certain cash payments; approximately $39.6 million of the net proceeds paid the cost of those transactions. The remaining net proceeds are intended for general corporate purposes. The issuance was upsized from an initial $400 million after initial purchasers exercised an option to purchase additional notes.
Planet Labs PBC is furnishing an information statement to notify stockholders of a board Election that became effective 40 days after notice is sent. The Record Date for approval was September 5, 2025, and the Consenting Stockholders who delivered written consent were William Marshall and Ulysses Trust 02021.1. The filing recounts the company’s 2021 Business Combination with dMY Technology Group IV that resulted in the current Planet Labs PBC structure.
Governance disclosures describe board structure and committees, independence determinations, director compensation changes effective July 11, 2024 (annual cash retainer reduced to $75,000; initial and annual RSU awards set at $175,000), and director and executive oversight roles. Executive compensation notes include CEO base salary reduction from $500,000 to $400,000, other named officer salary adjustments, a disclosed CEO total compensation of $4,746,341, a median employee compensation of $140,943, and a reported pay ratio of 33.7 to 1. The filing also describes Kevin Weil’s May 6, 2024 transition and related advisory and subsidiary agreements.